Browse Topical antibiotics topic

Subtopics (1) Health aspects

Articles 1-18 out of 18 article(s) Title Author Type Date Words Partial medial canal fibrosis. Ulubil, S. Arif Brief Article Feb 1, 2006 306 Topical antibiotics: strategies for avoiding ototoxicity. Haynes, David S. Jan 1, 2004 1811 The formation and management of middle ear granulation tissue in chronic ear disease. Roland, Peter S. Jan 1, 2004 1804 The evolution of ototopical therapy: from cumin to quinolones. Myer, Charles M., III Jan 1, 2004 1615 Ligand Pharmaceuticals' Panretin Gel for Aids-Related KS to Receive FDA Priority Review. Article Jul 13, 1998 460 Derma Sciences adds veteran healthcare sales and marketing executives; charged with repositioning products, increasing sales, broadening market niches and product penetration. May 9, 1997 646 Corporate Profile for NexMed Inc., dated May 2, 1997. May 2, 1997 339 DUSA Pharmaceuticals reports Phase III Levulan PDT Accrual update; and 1997 first quarter results. May 2, 1997 615 Procept receives patent for novel method of inhibiting HIV infection; U.S. patent covers topical administration of PRO 2000. Mar 31, 1997 337 NexMed completes private placement. Feb 18, 1997 152 Hi-Tech Pharmacal receives FDA approval to market generic form of Erythromycin Topical Solution. Oct 30, 1996 287 Procept to develop gel to prevent sexual transmission of HIV in women; Key preclinical results presented at AIDS conference. Sep 10, 1996 435 SmithKline Beecham's Bactroban Nasal Now Available; First Intranasal Product Approved for the Eradication of MRSA, a Resistant Bacteria Linked to Infection Outbreaks. Apr 29, 1996 685 Life Medical Sciences Inc. developing improved stability formulations of Cariel & Piliel; clinical trial to be modified; corrects erroneous Reuters report. Feb 9, 1996 226 ALPHARMA announces FDA approval of Albuterol Sulfate Syrup. Sep 27, 1995 216 Hygenics Pharmaceutical's first full-scale batch of concentrated base for its antimicrobial solution manufactured and shipped to Latin America. Aug 28, 1995 174 Chemex announces delay in NDA acceptance with no impact on its plans. Nov 17, 1994 306 LIFE MEDICAL SCIENCES, INC. REPORTS THIRD QUARTER RESULTS. Nov 15, 1994 998